Nitrosamine Impurities Affecting Drug-Drug Interaction Studies –
Learn More
Participate in a Study
Contact
Careers
Assays
Investigators
About
Why Celerion?
Management Team
Global Locations
News & Events
Services
Early Phase Services
Centers
Solutions
Volunteer Recruitment
Phase 2-3 Services
Clinical Trial Design
Feasibility
Project Management
Clinical Monitoring
Medical Monitoring
Bioanalytical Sciences
PK/PD
Immunogenicity
Biomarkers
Biosimilars
Gene Therapy
Metabolite Profiling
Drug Development & Regulatory Affairs
Data Management & Biometrics
Modeling and Simulation
Protocol Development
Clinical Data Sciences
Biostatistics
Pharmacokinetics / Pharmacodynamics (PK/PD)
Medical Writing and Reporting
Expertise
Therapeutic Areas
Respiratory Disease
Metabolic Disease
Oncology
Biosimilars
Vaccines
Renal / Hepatic Insufficiency
Cardiovascular Safety Studies
Tobacco Risk Evaluation
Product Labeling Studies
Innovations
ClinQuick®
Celexus®
ECG Core Lab
E-Lab Notebook
EDC
eTMF
Resources
Contact
Careers
Assays
Investigators
Participate in a Study
News & Events
Events
Use the search feature below to stay up to date on our latest events.
Search
Filter by:
All Tags
A. Jenni
A. Wyrzucki
ADC
ADME
Assay Development
Belfast
Bioanalysis
Bioanalytical
Bioanalytical Sciences
Biomarkers
Biosimilars
Biostatistic
Cardiovascular Safety Studies
Celexus
Centers
Clinical Data Sciences
Clinical Monitoring
Clinical Trial Design
ClinQuick
COPD
Data Management And Biometrics
Diabetes
Drug Development & Regulatory Affairs
Drug Development And Regulatory Affairs
Early Clinical Development
Early Development
Early Phase Services
Early Phase Services Solutions
Early Phase Volunteers
ECG Core Lab
EDC
Feasibility
Flow Cytometry
Global Clinical Development
H. Williams
Immunogenicity
L. Champion
Large Molecule
Lincoln
M. Pfenniger
Medical Monitoring
Medical Writing And Reporting
Metabolic Disease
Modeling And Simulation
NAFLD
NASH
NDA-enabling
Newsletter
Nicotine Risk Evaluation
Oncology
P. Struwe
Pharmacokinetic
Pharmacokinetics / Pharmacodynamics (PK/PD)
Pharmacovigilance
Pharmacy
Phase 2-3 Services
Phoenix
PK/PD
Product Labeling Studies
Project Management
Protocol Development
Radio Label
Renal / Hepatic Insufficiency
Respiratory Disease
Rifampin
Small Molecule
Test
Therapeutic Areas
Tobacco Risk Evaluation
Vaccine
Vaccines
Volunteer Recruitment
Continuing the Conversation: Audience Questions from ASCPT Journal Family Webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues”
12.01.2023 -
